Childhood Crohn's disease and the efficacy of enteral diets

Nutrition

Volumn 14, Issue 4, 1998, Pages 345-350

  Beattie, R Mark ^a   Bentsen, Beint S ^a   Macdonald, Thomas T ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Cytokine production; Enteral diets; Immunologic lesion; Inflammatory bowel disease; Mucosal healing; Nutrition treatment; Pediatric Crohn's disease

Indexed keywords

CROHN DISEASE; DIET THERAPY; EPITHELIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE MUCOSA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS);

EID: 0032054187     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)00493-0     Document Type: Article

References (73)

1. 1. Hildebrand H, Brydolf M, Holmquist L, et al. Incidence and prevalence of inflammatory bowel disease in children in south-western Sweden. Acta Paediatr 1994;83:640
2. 2. Cosgrove M, Al-Atia R, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 1996;74:460
3. 3. Brain CE, Savage M. Growth and puberty in chronic inflammatory bowel disease. In: Walker-Smith JA, MacDonald TT, eds. Chronic inflammatory bowel disease in childhood. London: Bailliere Tindall, 1994:83
4. 4. Navarro J, Fontaine JL, Mathe JC, et al. The treatment of Crohn's disease in the child: 12 cases [French]. Nouv Presse Med 1978;7:183
5. 5. Fernandez-Banares F, Cabre E, Gonzales-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994;s1:S55
6. 6. Ste-Marie M. Symposium on the treatment of inflammatory bowel disease in children and adolescents: nutritional therapy. Can J Surg 1982;25:495
7. 7. Navarro J, Vargas J, Cezard JP, Charrital JL, Polonovski C. Prolonged constant rate elemental nutrition in Crohn's disease. J Pediatr Gastroentrol Nutr 1982;1:541
8. 8. Integlia MJ, Shashidar H, Grand RJ. Paediatric inflammatory bowel disease. Curr Opin Gastroenterol 1996;12:345
9. 9. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995;108:1056
10. 10. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease: a meta-analysis of the randomised clinical trials. JPEN 1995;19:356
11. 11. Cezard JP, Touati G, Hougot JP, Fuare C, Besnard M, Navarro J. Workshop XV: Growth and development in paediatric IBD: nutritional treatment in paediatric IBD. In: Tytgat GNJ, Bartelsman JFWM, van Deventer S, eds. Falk symposium: inflammatory bowel disease. Amsterdam: Kluwer Academic, 1995:619
12. 12. Wu S, Craig RM. Intense nutritional support in inflammatory bowel disease. Dig Dis Sci 1995;40:843
13. 13. Fleming CR. Nutrition in patients with Crohn's disease: another piece of the puzzle (editorial). JPEN 1995:19:93
14. 14. Best WR, Becktel JM, Singleton JW, Kern F. Development of Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439
15. 15. Van Hees PAM, Van Elteren RH, Van Lier HJJ, Van Tongeren JHM. An index of inflammatory activity in patients with Crohn's disease. Gut 1980;21:279
16. 16. Lloyd-Still JD, Green OC. A clinical scoring system for chronic inflammatory bowel disease in children. Dig Dis Sci 1979;24:620
17. 17. Hyams I, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439
18. 18. Sanderson IR, Udeen S, Davies PSW, et al. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 61:123
19. 19. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in Crohn's disease. J Pediatr Gastroenterol Nutr 1993;7:75
20. 20. Ruuska T, Savilahti E, Maki M, et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994;19:175
21. 21. Papadopoulou A, Rawashdeh MO, Brown GA, et al. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr 1995;84:79
22. 22. Seidmann EG, Griffiths AM, Jones A, et al. The Canadian Paediatric Crohn's Disease Study Group: semielemental diet versus prednisolone in the treatment of active Crohn's disease in children and adolescents. Gastroenterology 1993;104:A778
23. 23. Azcue M, Rashid M, Griffiths A, et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997;41:203
24. 24. Modigliani R, Mary J, Simon J, et al. Clinical, biological and endoscopic picture of attacks of Crohn's disease. Gastroenterology 1991; 98:811
25. 25. Beattie RM, Schiffrin EJ, Donnet-Huges A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Therap 1994;8:609
26. 26. Nicholls S, Domizio P, Williams CB, et al. Cyclosporin as initial treatment for Crohn's disease. Arch Dis Child 1994;71:243
27. 27. Gassull MA, Fernandez-Banares F, Esteve Comas M. Nutrition in inflammatory bowel disease. In: Payne-James JJ, Grimble G, Silk D, eds. Artificial nutrition support in clinical practice. London: Edward Arnold, 1995:443
28. 28. Beluzzi A, Brignola C, Campieri M, et al. Effect of an enteric coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557
29. 29. Rigaud D, Cosnes J, Le Quintrec Y, Rene E, Gendre JP, Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease. Gut 1991;32:1492
30. 30. Gonzalez-Huix F, de Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993;34:778
31. 31. Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993;34:198
32. 32. Seidman EG, Boutlillier L, Weber AM, et al. Elemental diet versus prednisone as primary treatment of Crohn's disease. Gastroenterology 1986;90:A1625
33. 33. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988;94:603
34. 34. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996;38:543
35. 35. Teahon K, Bjarnarson I, Levi AJ. Elemental diets in the management of Crohn's disease: a ten year review. Gut 1990;31:133
36. 36. Lochs H, Steinhardt HJ, Klaus-Wentz B, et al. Comparison of enteral nutrition and drug treatment in active Crohn's disease: results of the European Cooperative Crohn's Disease Study IV. Gastroenterology 1991;101:881
37. 37. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1984;86:249
38. 38. Shanahan F. Current concepts of the pathogenesis of inflammatory bowel disease. Irish J Med Sci 1994;163:544
39. 39. Pavli P, Gibson PR. Pathogenic factors in inflammatory bowel disease. 2. Crohn's disease. Dig Dis 1992;10:72
40. 40. Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993;39:345
41. 41. Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992;33: 890
42. 42. Brandtzaeg P. Immunologic basis for coeliac disease, inflammatory bowel disease, and type B chronic gastritis. Curr Opin Gastroenterol 1991;7:450
43. 43. Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 1994;72:135
44. 44. Mullin GE, Lazenby AT, Harris ML, Bayless TM, James SP. Increased interleukin-2 mRNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102: 1620
45. 45. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2 and Interferon-γ secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127
46. 46. Arya SK, Wong-Staal F, Gallo RC. Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 1984;133:273
47. 47. Reed JC, Abidi AH, Alpers JD, Hoover RG, Robb RJ, Nowell PC. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J Immunol 1986;137:150
48. 48. Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321:845
49. 49. Targan SR, Hanauer SB, Van Deventer SJH, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med 1997;337:1029
50. 50. Michie HR, Spriggs DR, Manogue KR, et al. Tumour necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988;104:280
51. 51. Brenner DA, Buck M, Feitelberg SP, Chojkier M. Tumor necrosis factor-α inhibits albumin gene expression in a murine model of cachexia. J Clin Invest 1990;85:248
52. 52. Breese EJ, Michie CA, Nicholls SW, et al. Tumor necrosis factor-α producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455
53. 53. Breese EL, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 1995;9:547
54. 54. Seidman E, LeLeiko N, Alnent M, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991;12:424
55. 55. Groux H, Rouleau M, Bacchetta R, Roncarolo MG. T cell subsets and their cytokine profiles in transplantation and tolerance. Ann NY Acad Sci 1995;770:141
56. 56. Hodgson HJF, Wands IR, Isselbacher KJ. Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol 1978;32: 451
57. 57. Auer IO, Roder A, Frohlich J. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets. Gastroenterology 1984;86:1531
58. 58. Koster F, Pierce NF. Effect of protein deprivation on immunoregulatory cells in the rat mucosal immune response. Clin Exp Immunol 1985;60:217
59. 59. Lamont AG, Gordon M, Ferguson A. Oral tolerance in protein-deprived mice. II. Evidence of normal "gut processing" of ovalbumin, but suppressor cell deficiency, in deprived mice. Immunology 1987; 61:339
60. 60. Daly JM, Reynolds T, Sigal RK, Shou J, Liberman MD. Effect of dietary protein and amino acids on immune function. Crit Care Med 1990;18:S86
61. 61. Deitch EA. Bacterial translocation: the influence of dietary variables. Gut 1994;35:S23
62. 62. Steinhardt HJ, Loeschke K, Kasper H, Holtermuller KH, Schafer H European Cooperative Crohn's Disease Study (ECCDS): Clinical features and natural history. Digestion 1985;31:97
63. 63. Greenberg GR, Feagan BG, Martin F, et al. Oral budenoside for active Crohn's disease: Canadian inflammatory bowel disease study group. N Engl J Med 1994;331:836
64. 64. Wright NA, Poulsom R, Stamp G. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:2
65. 65. Poulsom R. Trefoil peptides. Baillieres Clin Gastroenterol 1996;10: 113
66. 66. Kindon H, Pothoulakis C, Rhim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: co-operative interaction with mucin glycoprotein. Gastroenterology 1995;109:516
67. 67. Chinery R, Playford RJ. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci 1995;88:401
68. 68. Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats. Gastroenterology 1996;10:489
69. 69. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262
70. 70. Peach S, Lock MR, Katz D, Todd IP, Tabaqchali S. Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group. Gut 1978;19:1034
71. 71. Keighley MRB, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander-Williams J. Influence of inflammatory bowel disease on intestinal microflora. Gut 1978;19:1099
72. 72. Axelsson CK, Iustesen T. Studies of the duodenal and fecal flora in gastrointestinal disorders during treatment with an elemental diet. Gastroenterology 1977;72:397
73. 73. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995;108:1617